undefined

Michel Sadelain

Director of the Initiative in Cell Engineering and Therapy at Columbia University and a pioneer in CAR T‑cell therapy research, discussing the history, mechanism, and clinical impact of CAR T treatments.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app